The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLeeds Group Regulatory News (LDSG)

Share Price Information for Leeds Group (LDSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 2.00 (22.222%)
Open: 10.00
High: 10.00
Low: 10.00
Prev. Close: 10.00
LDSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Feb 2024 07:00

RNS Number : 8686E
Leeds Group PLC
29 February 2024
 

Issued on behalf of Leeds Group plc Embargoed: 7.00am

Date: 29 February 2024

 

 

Leeds Group plc 

("Leeds Group" or "the Group" or "the Company'') 

Unaudited Interim Results for the six months ended 30 November 2023

The unaudited interim results of Leeds Group for the six months ended 30 November 2023 are presented as follows.

 

This announcement contains inside information for the purposes of UK Market Abuse Regulation and has been arranged for release by Jan G Holmstrom, Chairman. The Directors of the Company accept responsibility for the content of this announcement.

 

Enquiries: 

Leeds Group plc Cairn Financial Advisers LLP 

Dawn Henderson - 01937 547877 Sandy Jamieson / Liam Murray - 020 7213 0880

 

 

Chairman's Statement 

On 15 December 2023, the Board announced that they had conditionally agreed to sell the entire issued share capital of its subsidiary, Hemmers-Itex Textil Import Export GmbH ('Hemmers'), to a subsidiary of Nooteboom Bidco GmbH ('purchaser'). The cash consideration will be approximately £569,000 and is based on the net assets of Hemmers at 30 November 2023, excluding its properties, less an agreed discount. This figure differs from the figure stated in the circular as Hemmers made larger than expected losses in November. Leeds Group will retain three properties currently owned by Hemmers which have an aggregate net book value of £5,209,000.

 

The disposal was subject, inter alia, to the approval by Leeds Group shareholders at a general meeting and competition clearance from the German Cartel Office. The Leeds Group shareholders approved the proposed sale at a general meeting held on 9 January 2024 and on 22 January 2024, the Company received confirmation that the German Cartel Office had cleared the transaction to proceed. The Company is currently waiting for the purchaser to complete the refinancing of the existing Hemmers loans in order for the proposed sale to be completed. This is expected in March 2024. The assets of Hemmers have, therefore, been shown in the accounts as an asset held for sale and its operations have been classified as a discontinued operation.

Going forward the Company will have no trading activities as such although through LG Nordhorn Property GmbH ('LG Nordhorn'), it will own the three properties transferred from Hemmers and these properties will be leased back to Hemmers generating an expected average rental income of approximately £440,000 per annum over the next five years, which will cover the operating expenses of the Company for those five years.

Following the proposed sale, the Board will consider the future of the Group given the Group will be classed as an AIM Rule 15 Cash Shell. As such, the Company must make an acquisition or acquisitions which constitute a reverse takeover under Rule 14 of the AIM Rules within six months of Completion or be re-admitted to trading on AIM as an investing company under the AIM Rules (which requires the raising of at least £6 million) failing which the Ordinary Shares would then be suspended from trading on AIM pursuant to Rule 40 of the AIM Rules. Admission to trading on AIM would be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified.

 

 

 

 

 

Jan G Holmstrom

Chairman

29 February 2024

 

 

 

 

Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2023

 

 

Unaudited

6 months to 30 November 2023

Unaudited

6 months to 30 November 2022

Audited

Year to 31 May 2023

 

Continuing

operations

£000

Discontinued

operations

£000

Total

 

£000

Continuing

operations

£000

Discontinued

operations

£000

Total

 

£000

Continuing

operations

£000

Discontinued

operations

£000

Total

 

£000

 

Revenue

 

-

 

 11,042

 

 11,042

 

-

 

15,575

 

15,575

 

-

 

27,817

 

27,817

 

Cost of sales

 

-

(8,413)

(8,413)

 

-

 

(12,666)

 

(12,666)

 

-

 

(22,383)

 

(22,383)

 

 

 

Gross profit

-

2,629

2,629

-

2,909

2,909

-

5,434

5,434

 

 

 

Other income

-

-

-

-

75

75

-

171

171

Distribution costs

-

(743)

(743)

-

(1,363)

(1,363)

-

(2,203)

(2,203)

 

 

 

Impairment charge (note 5)

 

-

 

(4,487)

 

(4,487)

 

-

 

-

 

-

 

-

 

-

 

-

Gain on discontinued operation

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

138

 

 

138

Administrative costs

 

(215)

 

(1,951)

 

(2,166)

 

(88)

 

(1,576)

 

(1,664)

 

(229)

 

(3,820)

 

(4,049)

Total administrative costs

 

 

(215)

 

 

(6,438)

 

 

(6,653)

 

 

(88)

 

 

(1,576)

 

 

(1,664)

 

 

(229)

 

 

(3,682)

 

 

(3,911)

 

 

 

Operating (loss)/profit

 

(215)

 

(4,552)

 

(4,767)

 

(88)

 

45

 

(43)

 

(229)

 

(280)

 

(509)

 

 

 

Finance income/(costs)

 

103

 

(354)

 

(251)

 

103

 

(284)

 

(181)

 

208

 

 (592)

 

 (384)

 

 

 

(Loss)/profit before taxation

 

(112)

 

(4,906)

 

(5,018)

 

15

 

(239)

 

(224)

 

(21)

 

(872)

 

(893)

 

 

 

Taxation

-

-

-

-

113

113

-

53

53

 

 

 

 

(Loss)/profit for the period/year

 

(112)

(4,906)

(5,018)

 

15

 

(126)

 

(111)

 

(21)

 

(819)

 

(840)

 

 

 

 

Other comprehensive income for the period/year*

 

 

 

-

 

 

 

30

 

 

 

30

 

 

 

-

 

 

 

130

 

 

 

130

 

 

 

-

 

 

 

102

 

 

 

102

 

 

 

 

Total comprehensive (loss)/profit for the period/year attributable to the equity holders of the Company

 

 

 

 

 

 

 

(112)

 

 

 

 

 

 

 

(4,876)

 

 

 

 

 

 

 

(4,988)

 

 

 

 

 

 

 

15

 

 

 

 

 

 

4

 

 

 

 

 

 

19

 

 

 

 

 

 

 

(21)

 

 

 

 

 

 

 

(717)

 

 

 

 

 

 

 

(738)

 

 

 

 

 

 

 

 

Basic and diluted (loss)/profit per share

 

 

(0.4)p

 

 

(17.8)p

 

 

(18.2)p

 

 

0.1p

 

 

(0.5)p

 

 

(0.4)p

 

 

(0.1)p

 

 

(3.0)p

 

 

(3.1)p

 

*Other comprehensive income for the period/year relates it items that are or may be reclassified subsequently to profit or loss

Foreign operations - foreign currency translation differences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Financial Position

at 30 November 2023

Unaudited

As at

30 November

2023

£000

Unaudited

As at

30 November

2022

£000

Audited

As at

31 May

2023

£000

Assets

 

Non-current assets

Property, plant and equipment

5,209

6,689

6,487

Right-of-use assets

-

173

207

Intangible assets

-

53

46

 

 

Total non-current assets

5,209

6,915

6,740

 

Current assets

 

Inventories

-

11,227

8,218

Trade and other receivables

17

3,472

3,199

Cash and cash equivalents

94

1,845

234

Assets held for sale (note 5)

8,169

-

-

 

Total current assets

8,280

16,544

11,651

 

Total assets

13,489

23,459

18,391

 

 

Liabilities

 

Non-current liabilities

 

Loans and borrowings

-

(697)

(544)

Lease liabilities

-

(953)

(112)

 

 

Total non-current liabilities

-

(1,650)

(656)

 

 

Current liabilities

 

Trade and other payables

(93)

(2,699)

(1,353)

Loans and borrowings

-

(7,279)

(5,502)

Lease liabilities

-

(635)

(97)

Provisions

(345)

-

(344)

Liabilities directly associated with the assets held for sale (note 5)

 

(7,600)

 

-

 

-

 

Total current liabilities

(8,038)

(10,613)

(7,296)

 

 

Total liabilities

(8,038)

(12,263)

(7,952)

 

TOTAL NET ASSETS

5,451

11,196

10,439

 

Capital and reserves attributable to

equity holders of the Company

 

Share capital

3,279

3,279

3,279

Capital redemption reserve

1,113

1,113

1,113

Foreign exchange reserve

2,182

2,180

2,152

(Accumulated losses)/retained earnings

(1,123)

4,624

3,895

TOTAL EQUITY

5,451

11,196

10,439

 

 

 

 

 

 

Consolidated Cash Flow Statement

for the six months ended 30 November 2023

Unaudited

6 months to

30 November

2023

£000

Unaudited

6 months to

30 November

2022

£000

Audited

Year to

31 May

2023

£000

 

Cash flows from operating activities

 

 

Loss for the period/year

(5,018)

(111)

(840)

Adjustments for:

 

Government assistance credit

-

-

(59)

Depreciation of property, plant and equipment

294

399

608

Depreciation of right-of-use assets

43

56

103

Amortisation of intangible assets

-

-

6

Impairment charge

4,487

-

-

Finance expense - interest on bank loans

248

153

347

Finance expense - interest on lease liabilities

3

28

37

Gain on sale of property

-

(138)

(142)

Loss on sale of right-of-use assets

-

-

3

Gain on discontinued operation, net of tax

-

-

(138)

Taxation credit

-

(113)

(53)

 

57

274

(128)

Changes in:

 

Inventories

(60)

947

2,744

Trade and other receivables

15

(1,169)

(404)

Trade and other payables

254

499

(101)

Cash generated from operating activities

266

551

2,111

Interest paid on bank loans

(248)

(153)

(347)

Interest paid on lease liabilities

(3)

(28)

(37)

Receipt from government grant

-

-

59

Taxation received/(paid)

-

28

(32)

 

Net cash from operating activities

15

398

1,754

 

Cash flows from investing activities

 

Acquisition of property, plant and equipment

(19)

(22)

(51)

Proceeds from sale of property, plant and equipment

86

517

521

 

Net cash generated from investing activities

67

495

470

 

Cash flows from financing activities

 

Proceeds from bank loans

-

1,515

-

Proceeds from bank loans disposed of

-

-

868

Repayment of bank loans

(165)

(150)

(539)

Repayment of lease liabilities

(45)

(542)

(661)

 

Net cash (used in)/generated from financing activities

(210)

823

(332)

 

Net (decrease)/increase in cash and cash equivalents

(128)

1,716

1,892

Cash and cash equivalents at beginning of period/year

234

126

126

Effect of movements in exchange rates on cash held

-

3

(3)

Cash and cash equivalents disposed of

-

-

(1,781)

 

Cash and cash equivalents at end of period/year

106

1,845

234

 

Cash and cash equivalents

94

1,845

234

Cash held in assets held for sale

12

-

-

Cash and cash equivalents at end of period/year

106

1,845

234

 

 

 

Consolidated Statement of Changes in Equity

for the six months ended 30 November 2023

 

Unaudited

Share capital

 

£000

Capital redemption reserve

 

£000

Foreign exchange reserve

£000

(Accumulated losses)/

retained earnings

£000

Total equity

 

 

£000

At 1 June 2023

3,279

1,113

2,152

3,895

10,439

Loss for the period

-

-

-

(5,018)

(5,018)

Other comprehensive income

-

-

30

-

30

 

At 30 November 2023

3,279

1,113

2,182

(1,123)

5,451

 

Unaudited

Share capital

 

£000

Capital redemption reserve

 

£000

Foreign exchange reserve

£000

(Accumulated losses)/

retained earnings

£000

Total equity

 

 

£000

At 1 June 2022

3,279

1,113

2,050

4,735

11,177

Loss for the period

-

-

-

(111)

(111)

Other comprehensive income

-

-

130

-

130

 

At 30 November 2022

3,279

1,113

2,180

4,624

11,196

 

Audited

Share capital

 

£000

Capital redemption reserve

 

£000

Foreign exchange reserve

£000

(Accumulated losses)/

retained earnings

£000

Total equity

 

 

£000

 

At 1 June 2022

3,279

1,113

2,050

4,735

11,177

Loss for the year

-

-

-

(840)

(840)

Other comprehensive income

-

-

102

-

102

 

 

At 31 May 2023

3,279

1,113

2,152

3,895

10,439

 

The following describes the nature and purpose of each reserve within equity:

 

Reserve

Description and purpose

 

Capital redemption reserve

Amounts transferred from share capital on redemption of issued shares

Treasury share reserve

Cost of own shares held in treasury

Foreign exchange reserve

Gains/(losses) arising on retranslation of the net assets of overseas operations into sterling

(Accumulated losses)/retained earnings

Cumulative net gains/(losses) recognised in the consolidated statement of comprehensive income after deducting the cost of cancelled treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes to the Interim Results

for the six months ended 30 November 2023

 

1. General information

 

Leeds Group plc is an AIM listed public company, limited by shares and incorporated in England and Wales under the Companies Act and its number is 00067863. The address of the registered office is Craven House, 14-18 York Road, Leeds, Wetherby, LS22 6SL.

 

The interim results for the six months ended 30 November 2023 and 30 November 2022 are unaudited. The interim financial statements have been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards as adopted in the United Kingdom ("UK adopted IFRS") using the accounting policies and methods of computation that were applied when preparing the most recent financial statements for the year ended 31 May 2023. The Group has chosen not to comply with IAS 34 'Interim Financial Statement' in these interim financial statements.

 

The information presented for the year ended 31 May 2023 does not constitute the Company's statutory accounts but are extracted from the audited accounts. The financial statements for the year ended 31 May 2023 have been filed with the Registrar of Companies. The Independent Auditor's Report on the Annual Report and Financial Statements for the year ended 31 May 2023 was qualified on the basis that they were unable to obtain sufficient audit evidence in respect of the subsidiary KMR and its performance, as stated within the Consolidated Statement of Comprehensive Income under discontinued operations. Except for the qualification noted above the Independent Auditor's Report on the Annual Report and Financial Statements for the year ended 31 May 2023 did not contain a statement under section 498(2) of the Companies Act 2006 or section 498(3).

 

2. Accounting policies

 

Going Concern

When considering its opinion about the application of the going concern basis of preparation of the financial statements, the Directors have assumed that the proposed sale completes in March 2024. They have also prepared other forecasts and sensitivities in case the proposed sale does not complete. Based on all scenarios, the Directors are of the opinion that it is appropriate to apply the going concern basis of preparation to the financial statements.

 

2. Loss per share

Ordinary shares of 12 pence each used in the calculation of earnings per share:

Unaudited

6 months to

30 November

2023

£000

Unaudited

6 months to

30 November

2022

£000

Audited

Year to

31 May

2023

£000

 

 

Number of shares (basic and diluted)

27,320,843

27,320,843

27,320,843

 

3. Segmental information

 

Group external revenue

 

Unaudited

6 months to

30 November

2023

£000

Unaudited

6 months to

30 November

2022

£000

Audited

Year to

31 May

2023

£000

Discontinued operations

Hemmers

 

11,042

 

12,679

 

24,290

KMR

-

2,896

3,527

 

Group external revenue

11,042

15,575

27,817

 

 

 

 

Group loss before tax

Unaudited

6 months to

30 November

2023

£000

Unaudited

6 months to

30 November

2022

£000

Audited

Year to

31 May

2023

£000

Continuing operations

 

Holding company

(112)

15

(21)

 

Discontinued operations

 

Hemmers

(419)

(164)

(793)

Hemmers impairment charge (note 5)

(4,487)

-

-

KMR

-

(75)

(79)

(4,906)

(239)

(872)

 

Group loss before tax

(5,018)

(224)

(893)

 

Group net assets

 

Unaudited

As at

30 November

2023

£000

Unaudited

As at

30 November

2022

£000

Audited

As at

31 May

2023

£000

Continuing operations

 

Holding company

2,262

2,770

2,719

 

Discontinued operations

 

Hemmers

3,189

9,604

7,720

KMR

-

(1,178)

-

 

3,189

8,426

7,720

 

 

Group net assets

5,451

11,196

10,439

 

4. Analysis of net bank debt

 

Unaudited

As at

30 November

2023

£000

Unaudited

As at

30 November

2022

£000

Audited

As at

31 May

2023

£000

 

 

Cash on demand and on short term deposit

 

Cash and cash equivalents

94

1,845

234

Cash held in assets for sale

12

-

-

Total cash on demand and on short term deposit

106

1,845

234

 

 

Loans and borrowings

 

Loans and borrowings

 

Current loans and borrowings

-

(7,279)

(5,502)

Non-current loans and borrowings

-

(697)

(544)

-

(7,976)

(6,046)

Liabilities associated with assets held for sale

 

Current loans and borrowings

(5,509)

-

-

Non-current loans and borrowings

(396)

-

-

(5,905)

-

-

 

Total loans and borrowings

(5,905)

(7,976)

(6,046)

 

Net bank debt at end of period/year

(5,799)

(6,131)

(5,812)

 

 

 

 

 

5. Disposal subsidiary held for sale

 

On 15 December 2023, the Board signed a conditional agreement to sell the entire share capital of Hemmers, its trading subsidiary in Germany. Accordingly, the net assets of Hemmers have been presented as a subsidiary held for sale in these financial statements and classified as a discontinued operation. The sale is expected to complete in March 2024.

 

Impairment

The proposed sale price for Hemmers is based on the net assets as at 30 November 2023 excluding freehold properties with a net book value of £5,209,000, and its intercompany loan with the holding company of £2,589,000 less an agreed discount of £4,487,000. The non-monetary assets of Hemmers as at 30 November 2023 have, therefore, been written down by the amount of the discount which has been allocated on a pro-rata basis.

 

Assets and liabilities of subsidiary held for sale

At 30 November 2023, the subsidiary was stated at fair value and comprised the following assets and liabilities:

 

 

Unaudited

As at

30 November

2023

 £000

Assets held for sale

 

Plant and equipment

497

Right-of-use-assets

87

Intangible assets

23

Stock

4,372

Cash

12

Trade and other receivables

3,178

Assets held for sale

8,169

 

Liabilities associated with assets held for sale

 

Trade and other payables

(1,530)

Loans and borrowings

(5,905)

Lease liabilities

(165)

Liabilities associated with assets held for sale

(7,600)

 

Net fair vale

569

 

6. Forward-Looking Statements

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not a guarantee of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR UWORRSOUUUUR
Date   Source Headline
27th Mar 20247:00 amRNSCompletion of Disposal
25th Mar 20247:00 amRNSFurther re Disposal, Loan Agreements and RPTs
29th Feb 20247:00 amRNSHalf-year Report
31st Jan 20244:04 pmRNSFurther re Disposal of subsidiary
9th Jan 202412:20 pmRNSResult of General Meeting
15th Dec 20237:00 amRNSDisposal
22nd Nov 20233:42 pmRNSResult of AGM
24th Oct 20237:00 amRNSFinal Results & Notice of AGM
30th Jun 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSHalf-year Report
20th Dec 20223:35 pmRNSDirectorate Change
30th Nov 20222:55 pmRNSResult of AGM
30th Nov 202211:30 amRNSAGM Statement
8th Nov 202210:05 amRNSFinal Results & Notice of AGM
10th Oct 20227:00 amRNSTrading Update
29th Apr 202210:18 amRNSTrading Update
17th Jan 20227:00 amRNSHalf-year Report
23rd Nov 20211:13 pmRNSResult of AGM
23rd Nov 202111:46 amRNSAGM Statement
18th Oct 20217:00 amRNSFinal Results
18th May 20212:21 pmRNSTrading Update
17th Feb 202111:30 amRNSTrading Update
15th Jan 20217:00 amRNSHalf-year Report
7th Dec 20204:19 pmRNSCancellation of Treasury Shares & TVR
23rd Nov 202012:50 pmRNSResult of AGM
23rd Nov 202012:00 pmRNSAGM Statement
26th Oct 20207:00 amRNSHolding(s) in Company
22nd Oct 20207:00 amRNSFinal Results
31st Mar 20207:00 amRNSTrading Update and Change of Registered Office
3rd Feb 20207:00 amRNSHalf-year Report
13th Dec 201911:01 amRNSResult of AGM - Replacement
12th Dec 20191:18 pmRNSResult of AGM
12th Dec 201912:00 pmRNSAGM Statement
12th Nov 20197:00 amRNSFinal Results
17th May 201912:35 pmRNSTrading Update
25th Mar 20197:00 amRNSTrading Update
28th Jan 20197:00 amRNSHalf-year Report
4th Dec 20187:00 amRNSDirector/PDMR Shareholding
22nd Oct 201812:19 pmRNSResult of AGM
22nd Oct 20187:00 amRNSAGM Statement
3rd Oct 20187:00 amRNSTransaction in Own Shares and TVR
1st Oct 20188:32 amRNSTransaction in Own Shares and TVR
10th Aug 20187:00 amRNSFinal Results
6th Jul 20187:00 amRNSInvestment in Joint Venture
30th Apr 201811:48 amRNSTrading Update
22nd Jan 20187:00 amRNSHalf-year Report
21st Dec 201712:46 pmRNSDirector/PDMR Shareholding
19th Sep 20171:01 pmRNSResult of AGM
19th Sep 201712:00 pmRNSAGM Statement
10th Aug 20177:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.